Drug boosts snakebite survival time by half: study

June 26, 2011

Rubbing snakebites with an ointment that slows the functioning of lymph glands could boost survival times by 50 percent, according to a study released Sunday.

In experiments on humans and mice, researchers in Australia showed that a class of compounds called nitric oxide donors delays the entry of toxins from potentially deadly snakebites into the blood stream.

Nitric oxide (NO), a molecule involved in regulation of blood pressure and the control of , has been shown to in patients who suffer acute strokes.

The new finding is of more than academic interest: every year some 100,000 people worldwide die from snakebites, and another 400,000 must amputate limbs that have been injected with poison.

It has long been known that many snake venoms contain large molecules that transit the human body's before entering the .

Separately, scientists have also established that nitric oxide slows down a pumping mechanism within the lymphatic system, a part of the body's immune system that carries a clear fluid -- called lymph -- toward the heart.

Dirk van Helden, a researcher at the University of Newcastle in New South Wales, put these two facts together to suggest a possible treatment for snakebites.

"We hypothesised that a nitric oxide-releasing agent applied topically would slow lymphatic transit time and entry of the into the circulation, delaying onset of toxicity," he and his colleagues wrote in the study.

To test their theory, the researchers injected a venom-like substance into one foot of 15 volunteers, and measured the time it took for the substitute to reach lymph nodes in the groin.

The experiment was later repeated, except this time the drug-laced ointment was spread around the puncture within one minute of the injection.

Result: the transit time dropped from an average of 13 minutes to 54 minutes, four times slower.

Further experiments using real toxins in rats yielded roughly the same results.

Finally, the researchers compared the survival time in rats injected with venom that were treated with the ointment against those that were not, and found that the rats kept breathing 50 percent longer.

"These results point to a new method of snakebite first aid that may also be useful for bites to the torso or head," the researchers concluded.

Currently, the most common treatment is to immobilise the patient and restrict blood flow as much as possible until medical assistance is available.

Explore further: Research identifies potential targets for treatment of leishmaniasis

More information: A pharmacological approach to first aid treatment for snakebite, Nature Medicine (2011) doi:10.1038/nm.2382 . www.nature.com/nm/journal/vaop … nt/full/nm.2382.html

Abstract
Snake venom toxins first transit the lymphatic system before entering the bloodstream. Ointment containing a nitric oxide donor, which impedes the intrinsic lymphatic pump, prolonged lymph transit time in rats and humans and also increased rat survival time after injection of venom. This pharmacological approach should give snakebite victims more time to obtain medical care and antivenom treatment.

Related Stories

Research identifies potential targets for treatment of leishmaniasis

October 6, 2017
Brazilian researchers at the University of São Paulo's Bioscience Institute (IB-USP) are starting to unravel the molecular mechanisms by which the parasite that causes cutaneous leishmaniasis circumvents the host organism's ...

Research on nitric oxide-releasing nanoparticles reveals viable skin infection treatment

July 31, 2017
George Washington University (GW) researchers have found that topically applied nitric oxide-releasing nanoparticles (NO-np) are a viable treatment for deep fungal infections of the skin caused by dermatophytes, for which ...

New research shows promise for improving vascular access for hemodialysis patients

August 16, 2017
Approximately 500,000 Americans with end-stage renal disease rely on hemodialysis to survive. Hemodialysis requires repeated access to the blood. Failure to maintain adequate access to the vasculature is a major cause of ...

Leprosy turns the immune system against itself, study finds

August 24, 2017
Leprosy hijacks our immune system, turning an important repair mechanism into one that causes potentially irreparable damage to our nerve cells, according to new research that uses zebrafish to study the disease. As such, ...

Basis established for nitric oxide joining oxygen and carbon dioxide in respiratory cycle

April 10, 2015
Professor Jonathan Stamler's latest findings regarding nitric oxide have the potential to reshape fundamentally the way we think about the respiratory system - and offer new avenues to save lives. It may be time to rewrite ...

Nanoparticles used to prevent inflammatory acne through slow-released nitric oxide

July 15, 2015
GW researcher and dermatologist, Adam Friedman, M.D., and colleagues, find that the release of nitric oxide over time may be a new way to treat and prevent acne through nanotechnology. This research, published in the Journal ...

Recommended for you

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Telekinetic
1 / 5 (2) Jun 26, 2011
How great that I won't have to suck the poison and spit it out anymore.
Argon
not rated yet Jun 27, 2011
The title is a bit confusing, other than that very nice article!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.